COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report

Gooya Tayyebi1, Seyed Kazem Malakouti1, Behnam Shariati1

  • 1Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Insights

Rapidly progressive dementia diagnosis is challenging during COVID-19. This case highlights sporadic Creutzfeldt-Jakob disease, emphasizing accurate diagnosis for optimal patient care.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Neuroscience

Background:

  • The COVID-19 pandemic has complicated the diagnosis and management of non-COVID-19 neurological conditions.
  • Diagnostic performance and healthcare resource allocation were significantly impacted globally.

Observation:

  • A 57-year-old male presented with rapid cognitive decline, headache, diplopia, myalgia, gait instability, and psychiatric symptoms.
  • COVID-19-associated encephalitis was considered but ruled out through further investigations.

Findings:

  • The patient was ultimately diagnosed with sporadic Creutzfeldt-Jakob disease.
  • This rare neurodegenerative disease presents with a rapid and severe progression of neurological and psychiatric symptoms.

Implications:

  • Timely and accurate diagnosis of Creutzfeldt-Jakob disease is crucial for appropriate patient management.
  • Avoiding extensive diagnostic evaluations for alternative conditions conserves resources and reduces patient burden.